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Abstract
High homocysteine (HCy) levels are associated with lymphocyte-mediated inflammatory responses that are sometimes in turn related to
hypoxia. Because adenosine is a potent lymphocyte suppressor produced in hypoxic conditions and shares metabolic pathways with HCy, we
addressed the influence of high HCy levels on the hypoxia-induced, adenosine-mediated, alteration of lymphocyte viability. We treated mito-
gen-stimulated human lymphocytes isolated from healthy individuals and the human lymphoma T-cell line CEM with cobalt chloride (CoCl2)to
reproduce hypoxia. We found that CoCl2-altered cell viability was dose-dependently reversed using HCy. In turn, the HCy effect was inhibited
using DL-propargylglycine, a specific inhibitor of the hydrogen sulphide (H2S)-synthesizing enzyme cystathionine-c-lyase involved in HCy cata-
bolism. We then addressed the intracellular metabolic pathway of adenosine and HCy, and the role of the adenosine A2A receptor (A2AR). We
observed that: (i) hypoxic conditions lowered the intracellular concentration of HCy by increasing adenosine production, which resulted in high
A2AR expression and 3
0, 50-cyclic adenosine monophosphate production; (ii) increasing intracellular HCy concentration reversed the hypoxia-
induced adenosinergic signalling despite high adenosine concentration by promoting both S-adenosylhomocysteine and H2S production; (iii)
DL-propargylglycine that inhibits H2S production abolished the HCy effect. Together, these data suggest that high HCy levels prevent, via H2S
production and the resulting down-regulation of A2AR expression, the hypoxia-induced adenosinergic alteration of lymphocyte viability. We
point out the relevance of these mechanisms in the pathophysiology of cardiovascular diseases.
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Introduction
Homocysteine (HCy) is a thiol-containing amino-acid intermediate
produced during the synthesis of cysteine from methionine [1]. High
HCy concentrations are associated with lymphocyte-mediated inflam-
matory responses driven by immune mediators [2–4]. HCy metabo-
lism is also linked to the metabolism of adenosine [5, 6], a nucleoside
that potently alters lymphocyte viability via activation of its A2A recep-
tor (A2AR) [7]. Adenosine has therefore an anti-inflammatory activity
[8] particularly during hypoxia/ischaemia where it is produced in large
amounts at the sites of injury [9].
Hyperhomocysteinaemia results from genetic enzymatic deficien-
cies and/or nutritional defects that affect HCy metabolism [10]. Under
basal conditions, adenosine and HCy result from hydrolysis of S-ade-
nosylhomocysteine (SAH) via the SAH hydrolase, and in hyperhomo-
cysteinaemia conditions the hydrolase reaction reverses and SAH
accumulates at the expense of adenosine. Subsequently, facilitated
diffusion of plasma adenosine into the cell through equilibrative
nucleoside transporters [11] increases and the adenosine depletion
generated by this situation reduces stimulation of its cell surface
receptors [12]. This situation could contribute to pathological
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processes [5] by interfering, for example, with cardioprotective,
vasodilatory effects resulting from A2AR activation [13, 14] and
several epidemiological studies showed that high concentrations of
HCy are indeed associated with cardiovascular diseases [15–17].
Hydrogen sulphide, an end product of HCy catabolism via the
transsulfuration pathway, entered recently the family of gasotransmit-
ters along with NO and CO, because of the effects of H2S at the cellular
and molecular level [18]. This gas was also considered as an autocrine/
paracrine T-lymphocyte activator [19], and we recently reported that
H2S reverses the adenosinergic alteration of T-lymphocyte viability via
repression of the NF-jB, which down-regulates A2AR expression [20].
Based on this finding and on the literature reported above, we
undertook to delineate the relationship between HCy, adenosine and
A2AR expression in hypoxic conditions with particular emphasis on
the effects of H2S produced by high HCy levels on the hypoxia-
induced, adenosine-mediated (hypoxia-adenosinergic thereafter) sig-
nalling in lymphocytes.
Materials and methods
Peripheral blood lymphocyte (PBL) preparation
Blood samples were collected from brachial vein of three healthy donors
(two males and one female, 25, 38 and 42 years old respectively) after
written consent. The study methodologies conformed to the standards
set by the Declaration of Helsinki. Peripheral blood lymphocyte were
isolated according to manufacturer’s instructions using the Vacutainer
Cell Preparation Tube density gradient system (Beckton Dickinson,
Franklin lakes, NJ, USA). Cells (3 9 106 cells/ml) were then incubated
in the Roswell Park Memorial Institute (RPMI) 1640 medium supple-
mented with 2 mM L-glutamine, 10% foetal calf serum and penicillin/
streptomycin (100 U/ml, 100 lg/ml) for 1 hr at 37°C under 5% CO2 in
a 25 cm2 flask (10 ml/flask). Adherent monocytes were then discarded
and PBL present in culture supernatant were examined using the cell
viability assay described below.
Cell viability assay
Peripheral blood lymphocyte and CEM cells, a human lymphoma CD4+
T-cell line expressing A2AR [21], were cultured in RPMI 1640 medium
as described above. Cell viability was monitored in 24-well plates using
the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT) assay. The MTT assay produces a yellowish solution that is con-
verted to dark blue, water-insoluble, MTT formazan by oxidoreductase
enzymes of living cells [22]. MTT (0.5 mg in 100 ll of PBS, pH 7.3)
was added to each well containing cells (0.5 9 106 cells/ml) 3 hr prior
to the end of the 24-hr incubation period in culture medium containing
50–800 lM CoCl2 in the presence of phorbol myristate acetate (PMA,
50 ng/ml) and phytohemagglutinin (PHA, 5 lg/ml) as previously
reported [20]. Using the same procedure, we tested the effect of HCy
by incubating cells in a medium containing PMA + PHA and 50–
400 lM HCy that were added just prior to incubation with 100 lM
CoCl2 (i.e. the ED50 deduced from the previous experiment). In subse-
quent tests, and prior to the addition of CoCl2, cells in the culture
medium containing PMA + PHA were treated using 200 lM HCy (i.e.
the maximal effective dose) and 2.5–10 mM DL-propargylglycine (PPG).
All the reagents were titrated individually in terms of activity in prelimi-
nary experiments to determine a range of active concentrations that
were not cytotoxic. After treatment, cells were pelleted (10,000 9 g for
15 min.) and supernatants were discarded. The insoluble violet for-
mazan crystals contained in the cell pellets were dissolved using 1 ml
100% dimethyl sulfoxide and absorbance (A) was measured at 550 nm.
Cell culture experiments
CEM cells (0.5 9 106 cells/ml) were seeded in 75-cm2 flasks (50 ml/
flask) and stimulated using PMA + PHA as above. The hypoxic injury
was achieved by adding 100 lM CoCl2 to the culture medium for 24 hr.
To test the effect of HCy, cells were treated by adding 200 lM HCy just
prior to the addition of CoCl2. To test the effect of 10 mM PPG on cells
treated with HCy, the reagent was added concomitantly to HCy. In pre-
liminary experiments, effective doses of CoCl2, HCy and PPG were
determined using the cell viability assay described below. All the drugs
were added rapidly and sequentially as follows: PMA + PHA, HCy, PPG
and, in fine, CoCl2 whose presence triggered the hypoxia reaction. After
24-hr incubation in one of the following conditions (PMA + PHA con-
taining culture medium only, idem + CoCl2, +CoCl2 and HCy, +CoCl2,
HCy and PPG), living cells were counted using the Trypan Blue dye
exclusion method, aliquoted and centrifuged (1000 9 g for 5 min.). Cell
pellets were then frozen at 80°C until use. All reagents were from
Sigma-Aldrich (St. Louis, MO, USA).
A2AR expression
A2AR expression was assessed using a semi-quantitative Western blot
procedure described previously [23]. Briefly, cell pellets were lysed
using a 4% sodium dodecyl sulphate aqueous solution supplemented
with a protease inhibitor cocktail (Sigma-Aldrich) and a 15 min.-sonica-
tion treatment at 47 kHz. Cell lysates (0.5 9 106) were diluted in load-
ing buffer (65.2 mM Tris-HCl buffer, pH 8.3, containing 10% glycerol,
0.01% bromophenol blue and 5% 2-mercaptoethanol). Samples were
then analysed using 12% sodium dodecyl sulphate-polyacrylamide gel
electrophoresis and electroblotting onto polyvinylidene difluoride mem-
brane. Blots were incubated for 20 min. with an anti-A2AR mouse mAb
(Adonis; 1 lg/ml) [24]; an anti-b actin mAb (clone AC-15, Sigma-
Aldrich; 0.5 lg/ml) was used as total protein loading control. Blots were
then processed using horseradish peroxidase-labelled antimouse anti-
bodies and chemiluminescent substrate (SuperSignal West Femto;
Pierce Biotechnology, Rockford, IL, USA). Densitometry analysis of the
A2AR band at 45 kDa was performed with a Kodak Image Station 440CF
(Eastman Kodak Company, Rochester, NY, USA) and the ImageJ soft-
ware (NIH). Results were expressed as arbitrary units (AU) defined as
pixels of one peak versus the sum of peaks (percent).
Adenosine and inosine assays
Intracellular adenosine and inosine concentrations were measured as
previously described [25] using a high performance liquid chromatogra-
phy system equipped with a diode array detector (Chromsystems,
Munich, Germany). To prevent adenosine degradation, pellets of frozen
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cells (3 9 106) were mixed with 500 ll of a cold stop solution
[0.2 mM dipyridamole, 4.2 mM ethylenediaminetetraacetic acid, 5 mM
erythro-9-(2-hydroxy-3-nonyl) adenine, 79 mM a-b methylene adeno-
sine 50diphosphates and 1 IU/mL heparin sulphate in NaCl 0.9%]. Pro-
teins were precipitated using 1 N perchloric acid and the supernatant
was injected into a LiChrospher C18 column (Merck, Darmstad, Ger-
many). Adenosine and inosine were identified in the same run by their
elution time and spectrum. Measurements were made by comparison of
peak areas versus those obtained using adenosine and inosine standard
solutions. The intra-assay and interassay coefficients of variation ranged
from 1% to 3% for both products.
Adenosine deaminase (ADA) activity
Adenosine deaminase activity was measured as previously described
[23]. Briefly, cells (1.5 9 106) were lysed using 250 ll of ultra-pure
water, mixed with 750 ll of 28 mM adenosine in 0.9% NaCl and incu-
bated for 36 min. at 37°C. The reaction was stopped by immersion of
the samples in ice water. Ammonium production resulting from adeno-
sine degradation by ADA was determined using a Synchron LX 20 anal-
yser (Beckman Coulter Inc., Villepinte, France). The intra-assay and
interassay coefficients of variation ranged from 3% to 5%.
HCy and SAH assays
HCy and SAH concentrations in cell pellets were measured using dedi-
cated ELISA kits (Cusabio, Wuhan Huamei Biotech Co., Ltd, Wuhan,
Hubei Province, China). These assays use a quantitative sandwich
enzyme immunoassay technique where HCy or SAH are trapped onto an
antibody-coated plate prior to detection using a biotin-conjugated anti-
body specific for HCy or SAH and an avidin-conjugated horseradish per-
oxidase. For these assays, 2.5 9 106 and 0.5 9 106 cells for HCy and
SAH, respectively, were lysed using 100 ll of 0.25% dodecyl trimethyl
ammonium bromide in the assay buffer prior to transfer to microplate
according to manufacturer’s instructions.
H2S assay
H2S production by cells was measured using the methylene blue
method following trapping of the sulphides present in the culture med-
ium using zinc acetate in alkaline conditions [26]. Briefly, culture super-
natants (50 ml; 0.5 9 106 cells/ml) were mixed with 0.5 g of Zn
acetate and 630 ll NaOH 10 N prior to centrifugation at 3000 9 g for
10 min. The supernatants were removed by decantation and the Zn sul-
phide pellets were washed once with 25 ml ultra-pure water. The pellets
were then suspended in 1 ml ultra-pure water and vigorously shaken.
One hundred microlitres of 20 mM N,N dimethyl-p-phenylenediamine
sulphate in 7.2 N HCl was then added followed by 100 ll of 30 mM
FeCl3 in 1.2 N HCl and the tubes were shaken again. After 20 min. incu-
bation at room temperature in the dark, the samples were centrifuged
and the resulting methylene blue dye in the supernatant was measured
at 670 nm. The calibration curve of absorbance versus sulphide con-
centration was obtained using known concentrations of NaHS, a H2S
donor. The H2S concentration was taken as 30% of the NaHS concen-
tration in the calculation [27].
30, 50-cyclic AMP (cAMP) assay
The concentrations of cAMP present in cell pellets were measured using
the Amersham Biotrak kit (GE Healthcare Life Sciences, Bucking-
hamshire, UK) that combines the use of a peroxidase-labelled cAMP
conjugate and a specific antiserum immobilized on microplates. Cells
(1 9 106) were lysed using 100 ll of 0.25% dodecyl trimethyl ammo-
nium bromide in the assay buffer prior to transfer to microplate wells
to carry out the competitive enzyme immunoassay according to manu-
facturer’s instructions.
Statistical analysis
Each assay performed in duplicate was repeated three times. Data
(mean  S.D.) were compared using the one-way ANOVA with the Fish-
er’s least significant difference test. Differences with P < 0.05 were
considered to be statistically significant.
Results
HCy prevents the hypoxia-induced alteration of
lymphocyte viability
Freshly isolated PBL were used to address the authentic cell situa-
tion, whereas the human lymphoma T-cell line CEM was used
because it constitutes a cell material whose characteristics are well
documented and stable. We mimicked classically the inflammatory
context using PMA (5 lg/ml) and PHA (50 ng/ml), and we repro-
duced the hypoxia-induced effects using a 50–800 lM CoCl2 treat-
ment, a widely used method preventing HIF-1a degradation
[28,29] that was recently validated in much detail in this exact cel-
lular model [20]. CoCl2 also mimics hypoxia/ischaemia responses
by inducing oxidative stress and inflammation [30–33]. Various
parameters (cell density, CoCl2 concentration, treatment duration)
were tested in preliminary experiments (data not shown) using the
MTT assay to determine the conditions used subsequently. We
then choose a low cell density (0.5 9 106 cells/ml) to avoid cell
confluency during the experiment, and a long time exposure
(24 hr) to drugs (CoCl2, HCy, PPG) to mimic a chronic situation.
As previously obtained with more cells and a shorter time [20].
Figure 1 shows that CoCl2 treatment affected in a dose-dependent
manner the viability of resting PBL (Fig. 1A) and CEM cells
(Fig. 1B), PMA + PHA stimulation further increasing the CoCl2
effect. We next tested the effect of 50–400 lM HCy on lympho-
cyte viability in a PMA + PHA-containing culture medium in the
presence, or in the absence, of CoCl2. A 100 lM CoCl2 concentra-
tion was chosen to mimic hypoxic conditions because it corre-
sponded to the concentration that reproducibly induced the half-
maximal effect on stimulated PBL (Fig. 1A) and CEM cell (Fig. 1B)
viability. In the absence of CoCl2, HCy did not affect cell viability,
whereas the effect resulting from CoCl2 treatment for 24 hr was
reversed in a dose-dependent manner using HCy in PBL (Fig. 1C)
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and CEM cell cultures (Fig. 1D). We previously obtained similar
results using NaHS, a H2S donor [20].
These data indicate that high HCy levels promoted lymphocyte
survival in hypoxic conditions, and we used subsequently the maxi-
mal effective concentration (200 lM) of HCy.
PPG modulation of HCy effect
PPG is a specific inhibitor of cystathionine-c-lyase (CSE), and conse-
quently an agent that represses the CSE-mediated H2S production
[34]. To address the mode of action of HCy, we examined using 2.5–
10 mM PPG whether HCy acted via its degradation product H2S that
down-regulates A2AR expression [20]. Using a high concentration
(200 lM) of HCy, and in a context mimicking chronic hypoxia (24 hr
incubation with 100 lM CoCl2), PPG treatment decreased in a dose-
dependent manner the viability of stimulated PBL (Fig. 2A) and CEM
cells (Fig. 2B) versus the ‘hypoxia + hyperhomocysteinemia’ condi-
tion.
These data suggest that the effect of HCy on cell viability was
reversed by CSE inhibition, and resulted therefore from H2S produc-
tion. To further delineate this mechanism, we used in the next experi-
ments the highest concentration of PPG (10 mM) we tested.
Adenosine metabolism
In hypoxic conditions, adenosine is produced intracellularly from ATP
and can be secreted via equilibrative nucleoside transporters [35]. In
the cell, adenosine can be degraded into inosine by ADA. Adenosine
can be also produced in the extracellular environment by the ectoAT-
Pase/apyrase CD39 and ectonucleotidase CD73 [36] prior to its
degradation by ADA associated at the cell surface via CD26 [37]. In
lymphocyte population, extracellular adenosine can be produced from
ATP by the CD4+, CD25+ regulatory T cells that express both CD39
and CD73 at high levels [38].
Here, we focused on the intracellular adenosine metabolism by
testing adenosine and inosine levels as well as ADA activity in lysates
of stimulated CEM cells cultured in various conditions. The results are
given in Figure 3A: (i) CoCl2 treatment induced a rise in cellular con-
centrations of adenosine and inosine (4.17 versus 2.68 lM and 9.09
versus 2.67 lM in basal conditions respectively), the latter resulting
Fig. 1 Cell viability following CoCl2- and HCy-treatments. The viability index of PBL (A) and CEM cells (B), resting or stimulated using PMA+PHA
and incubated with 50–800 lM CoCl2 for 24 hr was monitored using the MTT assay. Incubation with 50–400 lM HCy in the presence, or not, of
100 lM CoCl2 was similarly tested using stimulated PBL (C) and CEM cells (B). The dark blue dye produced by living cells was spectrophotometri-
cally measured. Data are given as A550 nm value (mean  S.D., n = 3).
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probably from the increase in ADA activity (6.68 versus 3.03 IU) pro-
duced to counteract the elevated adenosine production generated by
hypoxia; (ii) a treatment combining CoCl2 and HCy tended to further
increase the concentration of adenosine generated by hypoxia (5.50
versus 4.17 lM in hypoxia) while ADA activity and the resulting ino-
sine concentration decreased (2.99 versus 6.68 IU and 8.23 versus
9.09 lM respectively); (iii) a treatment combining CoCl2 and HCy
together with PPG to inhibit H2S produced via HCy catabolism did not
modify adenosine concentration (5.32 versus 5.50 lM in the ‘hypox-
ia + hyperhomocysteinemia’ condition) but increased inosine pro-
duction (13.10 versus 8.23 lM), a result which was consistent with
the parallel increase in ADA activity (6.32 versus 2.99 IU).
These results suggested that the recovery of lymphocyte viability
resulting from HCy treatment (Fig. 1C and D) was not because of a
decreased production of adenosine since in fact its intracellular con-
centration increased (Fig. 3A).
HCy metabolism
During the conversion of methionine to HCy, S-adenosylmethionine
is produced from ATP. After demethylation, SAH is generated and
subsequently degraded by the SAH hydrolase into HCy and adeno-
sine that are quickly used in basal conditions, the enzyme being
also able to function in the opposite direction [39]. HCy may be
then remethylated to methionine or it may be condensed with ser-
ine to form cystathionine and then cysteine via the transsulfuration
pathway [40]. H2S, an end product of the pathway, is produced
by cystathionine b-synthase and CSE from HCy during T-cell acti-
vation [19]. In the following experiments, we focused on H2S pro-
duction by CSE because: (i) CSE controls the metabolism of
cysteine into H2S, pyruvate and NH4
+ [41]; (ii) CSE is the main
player in hyperhomocysteinaemia conditions [42] and iii) CSE can
be specifically inhibited using PPG [34].
The HCy metabolism in lymphocyte was studied by testing
HCy and SAH concentrations in lysates of stimulated CEM cells
cultured in various conditions while H2S intracellularly produced
and subsequently secreted in the culture medium was measured
in the culture supernatant. Our findings are given in Figure 3B: (i)
following CoCl2 treatment, HCy and hence H2S concentration,
decreased versus basal conditions (3.01 versus 3.59 lM and 0.81
versus 1.01 lM respectively). Conversely, SAH production
increased (4.47 versus 4.07 lM) as a result of the hypoxia-
induced production of adenosine; (ii) a treatment combining
100 lM CoCl2 and 200 lM HCy in the culture medium markedly
increased intracellular HCy concentration (4.63 versus 3.01 lM in
hypoxia); this situation stimulated intracellular SAH production
(5.34 versus 4.47 lM), which in turn promoted HCy degradation
via the transsulfuration pathway into H2S that strongly increased
in culture medium (1.31 versus 0.81 lM); (iii) a treatment com-
bining CoCl2, HCy and PPG did not significantly alter the concen-
tration of SAH and HCy (5.03 versus 5.34 lM and 4.61 versus
4.63 lM in the ‘hypoxia + hyperhomocysteinaemia’ condition
respectively) but strongly decreased H2S production (0.71 versus
1.31 lM).
These data further support the conclusion that hyperhomocys-
teinaemia reversed the hypoxia-adenosinergic alteration of lympho-
cyte viability via H2S production.
Adenosinergic signalling
Adenosine inhibits lymphocyte viability mainly via A2AR signalling and
stimulation of adenylyl-cyclase and GS-proteins [43,44], which con-
trols in turn a plethora of biological processes [45]. We addressed
here the hypoxia-adenosinergic lymphocyte signalling by testing A2AR
expression, cAMP production and viability of stimulated CEM cells
cultured in various conditions. The data are given in Figure 3C: (i)
CoCl2 treatment increased A2AR expression and cAMP production
compared with the basal situation (24.0 versus 19.1 AU and 1902
versus 643 fmol/well respectively). This result reflected the binding
of adenosine produced by the cell to an increasing number of A2AR,
Fig. 2 Effect of PPG in hypoxia and hyperhomocysteinaemia conditions.
PMA+PHA-stimulated PBL (B) and CEM cells (B) treated with 100 lM
CoCl2 and 200 lM HCy for 24 hr were incubated with 2.5–10 mM PPG.
The viability index was monitored using the MTT assay. Data are given
as A550 nm value (mean  S.D., n = 3). Controls were cells incubated
with/without 100 lM CoCl2 and/or 200 lM HCy. Statistical significance
(P < 0.05) was indicated by brackets where applicable.
ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
5
J. Cell. Mol. Med. Vol XX, No X, 2016
which decreased lymphocyte viability as shown using the MTT assay
(A550 nm = 0.56 versus 2.11 in the basal conditions); (ii) a treatment
combining CoCl2 and HCy reversed the inhibitory effect on viability
(A550 nm = 1.53 versus 0.56 in hypoxia) by decreasing A2AR expres-
sion and the resulting cAMP production (18.6 versus 24.0 AU and
947 versus 1902 fmol/well respectively); (iii) a treatment combining
CoCl2, HCy and PPG prevented the effect of HCy and increased A2AR
expression as well as cAMP production (21.2 versus 18.6 AU and
1638 versus 947 fmol/well in the ‘hypoxia + hyperhomocysteinaemia’
condition respectively), cell viability decreasing (A550 nm = 0.75 ver-
sus 1.53) to a value close to that found in the ‘hypoxia’ condition
(A550 nm = 0.56).
These results indicate that the loss of the hypoxia-adenosiner-
gic alteration of lymphocyte viability observed in the presence of
HCy (Fig. 1C and D) mainly depended on the decreased level of
A2AR expression (Fig. 3C) resulting from H2S production
(Fig. 3B).
Discussion
We found here that in CoCl2-induced hypoxic conditions, high HCy
levels increased H2S production, which down-regulated A2AR expres-
sion and repressed the potent hypoxia-adenosinergic alteration of
lymphocyte viability. We performed preliminary experiments in which
the monitoring of cell viability was used to dissect HCy regulation of
hypoxia-adenosinergic signalling in lymphocytes. We conducted four
experimental conditions in culture medium supplemented with
PMA + PHA: the control situation, hypoxia, hypoxia and hyperhomo-
cysteinaemia, and hypoxia and hyperhomocysteinaemia in the pres-
ence of PPG. We previously reported using the same CEM cell line
that hypoxia stimulates adenosinergic signalling [23] and that A2AR
stimulation decreases lymphocyte viability [20, 21]. Here, we con-
firmed these previous data and detailed the metabolic pathways of
HCy and adenosine that are interdependent and involved in the control
of lymphocyte viability (see Fig. 4 for an overview).
Fig. 3Metabolism of adenosine and HCy; adenosinergic signalling. Intracellular adenosine/inosine concentrations, as well as ADA activity, were mea-
sured in cell lysates (A). Intracellular SAH and HCy concentrations were measured in cell lysates, H2S being measured in culture supernatants (B).
A2AR expression, cAMP concentration and viability of the cells were also measured (C). PMA+PHA-stimulated CEM cells were cultured for 24 hr in
four experimental conditions: the ‘control’ condition (stimulated cells), ‘hypoxia’ (+100 lM CoCl2), ‘hypoxia+hyperhomocysteinaemia’ (+200 lM
HCy) and ‘hypoxia + hyperhomocysteinaemia’ in the presence of 10 mM PPG. Results are mean  S.D., n = 3. Statistical significance (P < 0.05)
was indicated by brackets where applicable. Specific A2AR bands (45 kDa) from a representative Western blot are shown in the insert.
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Firstly, we found that hypoxia increased intracellular adenosine
concentration to form SAH at the expense of HCy via the SAH hydro-
lase. In basal conditions, the hydrolase tends to produce adenosine
and HCy from SAH because these products are rapidly catabolized
[39]. Under hypoxic conditions, intracellular adenosine synthesis
increases, which results in a shift of the enzymatic reaction towards
SAH production from adenosine and HCy as shown here. A major
consequence is that HCy is no longer catabolized to form H2S, and
this situation prevents the known down-regulation of adenosinergic
signalling by H2S [20]. Taking into account that lymphocytes, in par-
ticular T lymphocytes, play a pivotal role in interaction with other
immune cells such as monocytes and neutrophils in an inflammatory
context, repressing the lymphocyte response in hypoxic condition
can contribute to the protective effect of A2AR activation, notably in
cardiovascular disease [46]. In the heart, it is also noteworthy that
production of adenosine following hypoxia/ischaemia has positive
effects on the vasculature via the A2AR-mediated coronary vasodila-
tion process [47–49]. Thus, during hyperhomocysteinaemia in hypox-
ic/ischaemic conditions, the catabolism of HCy into H2S and its
beneficial action on lymphocyte viability may be of particular impor-
tance regarding the onset and progression of cardiovascular disor-
ders that generally include a strong inflammatory background [15].
Secondly, when high extracellular concentrations of HCy were
added to the cell environment to mimic hyperhomocysteinaemia,
HCy entered the cell by transporters similar to those for cysteine
and cystine [50]. In these conditions, intracellular HCy was no
longer the limiting substrate for the production, together with ade-
nosine, of SAH that strongly increased. The resulting high SAH
concentration then forced the SAH hydrolase-mediated reaction to
reverse and produce, as in basal conditions, HCy and adenosine
that accumulated into the cell. Excess of intracellular HCy pro-
duced from SAH could be in turn degraded to generate H2S that
repressed both ADA activity and A2AR expression. The resulting
low ADA activity enabled to increase intracellular adenosine con-
centration and to decrease inosine production, whereas the low
A2AR expression restored the lymphocyte viability.
Thirdly, we further showed that HCy reversed the suppressive
effect of hypoxia on lymphocyte viability via its catabolism into H2S,
PPG preventing the H2S inhibitory effect on both ADA activity and
A2AR expression. In these conditions, adenosine could then exit the
cell to activate the highly expressed A2AR that, in turn, produced high
level of cAMP as in hypoxic conditions, whereas excess of intracellu-
lar adenosine was catabolized by ADA into inosine. We observed,
however, that PPG did not increase intracellular homocysteine level,
suggesting that homocysteine was metabolized further into cys-
tathionine by cystathionine b-synthase but not into the H2S end pro-
duct that requires the CSE activity. Moreover, the increase in H2S
production triggered by HCy was completely abolished by PPG. These
data are significant as they provide additional evidence that CSE is a
central player in H2S production in lymphocytes [41]. By showing
using PPG the H2S-mediated hyperhomocysteinaemia effect on the
hypoxia-adenosinergic signalling in lymphocytes, we also support
here the pro-inflammatory role attributed to H2S [51] as well as its
repressive action on A2AR expression [20].
These results show that HCy down-regulates A2AR expression in
hypoxic conditions via H2S production. We propose that this mecha-
Fig. 4 Proposed overview of HCy modula-
tion of the adenosinergic signalling in lym-
phocytes. Four experimental cell culture
conditions are considered: the ‘control’
condition (PMA+PHA-stimulated cells) (1),
‘hypoxia’ (2), ‘hypoxia+hyperhomocys-
teinaemia’ (3) and ‘hypoxia+hyperhomo-
cysteinaemia’ in the presence of PPG (4).
Up/down arrows represent the increase/
decrease in a parameter respectively. The
thickness of the arrow reflects the level of
the parameter. CoCl2-mediated hypoxia
induces intracellular production of adeno-
sine that can exit the cell through equili-
brative nucleoside transporters. Adenosine
stimulates A2AR that triggers the cAMP-
mediated suppressive signal. HCy is added
to the cell medium. H2S is produced from
HCy by CSE that is inhibited by PPG. H2S
represses ADA production and A2AR
expression.
ª 2016 The Authors.
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nism has strong implications for immunosuppression, and particu-
larly for patients with cardiovascular diseases and severe hyperhomo-
cysteinaemia that was shown to be associated with inflammation and
cardiovascular complications. Our findings may provide clues to
explain why hyperhomocysteinaemia constitutes a risk factor in car-
diovascular diseases [15–17] and may therefore help to define new
therapeutic strategies.
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